Immunohistochemical markers are essential to the diagnosis, with an initial mesothelial cell panel which may include calretinin, CK 5/6, WT-1 and D2-40 being used to differentiate mesothelial cell origin from metastatic carcinomas. The gene discussed is KRT5; the disease is metastatic carcinoma.